A randomized, prospective, double-blind study to evaluate the effects on lipid profile of combined Ezetimibe and Simvastatin therapy as compared to Simvastatin alone in people with type 2 diabetes
Phase 1
- Conditions
- Effects of Ezetimibe-simvastatin combined therapy in ameliorating the lipid profile and the overall cardiovascular and renal risk profile of patients with type 2 diabetesMedDRA version: 6.1Level: PTClassification code 10049746
- Registration Number
- EUCTR2004-004525-99-IT
- Lead Sponsor
- IST. DI RICERCHE FARMACOLOG. M. NEGRI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 108
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method